Startups set off new wave of mRNA therapeutics

Elie Dolgin • September 2, 2021

After the vaccine triumphs of Pfizer/BioNTech and Moderna, a raft of startups is developing mRNA, circular RNA and self-amplifying RNA therapeutics.

A cadre of new startups are building next-generation RNA platform technologies designed to solve some of the unique challenges associated with using conventional mRNA tools as therapeutics.


Read more at Nature Biotechnology.

Tubes of blood, one looks like an hourglass but with a woman's head
By Elie Dolgin April 16, 2025
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebra wearing video camera-equipped collar
By Elie Dolgin February 13, 2025
Zebras and giraffes offer one another protection without food competition.